Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Yu-ting Chou"'
Autor:
Lin-Yu Chen, Yu-Ting Chou, Phui-Ly Liew, Ling-Hui Chu, Kuo-Chang Wen, Shiou-Fu Lin, Yu-Chun Weng, Hui-Chen Wang, Po-Hsuan Su, Hung-Cheng Lai
Publikováno v:
Journal of Ovarian Research, Vol 17, Iss 1, Pp 1-6 (2024)
Externí odkaz:
https://doaj.org/article/60f9ff7b82144ef9bb50abed68080213
Autor:
Lin-Yu Chen, Yu-Ting Chou, Phui-Ly Liew, Ling-Hui Chu, Kuo-Chang Wen, Shiou-Fu Lin, Yu-Chun Weng, Hui-Chen Wang, Po-Hsuan Su, Hung-Cheng Lai
Publikováno v:
Journal of Ovarian Research, Vol 17, Iss 1, Pp 1-12 (2024)
Abstract Background Ovarian cancer is the most lethal gynecological cancer. As the primary treatment, chemotherapy has a response rate of only 60–70% in advanced stages, and even lower as a second-line treatment. Despite guideline recommendations,
Externí odkaz:
https://doaj.org/article/ad9976421da742c6a2aa45c571630064
Autor:
Anita S La'ah, Ping‐Hsing Tsai, Aliaksandr A. Yarmishyn, Lo‐Jei Ching, Chih‐Ying Chen, Yueh Chien, Jerry Chieh‐Yu Chen, Ming‐Long Tsai, Yi‐Chen Chen, Chun Ma, Po‐Kuei Hsu, Yung‐Hung Luo, Yuh‐Min Chen, Guang‐Yuh Chiou, Kai‐Hsi Lu, Wen‐Chang Lin, Yu‐Ting Chou, Mong‐Lien Wang, Shih‐Hwa Chiou
Publikováno v:
Advanced Science, Vol 11, Iss 38, Pp n/a-n/a (2024)
Abstract NK2 Homeobox 1 (NKX2‐1) is a well‐characterized pathological marker that delineates lung adenocarcinoma (LUAD) progression. The advancement of LUAD is influenced by the immune tumor microenvironment through paracrine signaling. However,
Externí odkaz:
https://doaj.org/article/3d23080e0cf742cf9d8128334fa2c505
Autor:
Franziska Haderk, Yu-Ting Chou, Lauren Cech, Celia Fernández-Méndez, Johnny Yu, Victor Olivas, Ismail M. Meraz, Dora Barbosa Rabago, D. Lucas Kerr, Carlos Gomez, David V. Allegakoen, Juan Guan, Khyati N. Shah, Kari A. Herrington, Oghenekevwe M. Gbenedio, Shigeki Nanjo, Mourad Majidi, Whitney Tamaki, Yashar K. Pourmoghadam, Julia K. Rotow, Caroline E. McCoach, Jonathan W. Riess, J. Silvio Gutkind, Tracy T. Tang, Leonard Post, Bo Huang, Pilar Santisteban, Hani Goodarzi, Sourav Bandyopadhyay, Calvin J. Kuo, Jeroen P. Roose, Wei Wu, Collin M. Blakely, Jack A. Roth, Trever G. Bivona
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Targeted therapy is effective in many tumor types including lung cancer, the leading cause of cancer mortality. Paradigm defining examples are targeted therapies directed against non-small cell lung cancer (NSCLC) subtypes with oncogenic alt
Externí odkaz:
https://doaj.org/article/be0a7eca3725431ab19bfe58739629b9
Publikováno v:
Terrestrial, Atmospheric and Oceanic Sciences, Vol 35, Iss 1, Pp 1-15 (2024)
Abstract In order to avoid the casualties caused by damaged buildings during strong earthquakes, it’s important and essential to understand the seismic design specifications of buildings. The motion of a building depends on the interferometry of bu
Externí odkaz:
https://doaj.org/article/3863632684724e1fabecc6b6bf970c1b
Autor:
Shih‐Hsin Hsiao, Wan‐Ting Chen, Chi‐Li Chung, Yu‐Ting Chou, Sey‐En Lin, Shiao‐Ya Hong, Jer‐Hwa Chang, Tzu‐Hao Chang, Li‐Nien Chien
Publikováno v:
Cancer Medicine, Vol 11, Iss 10, Pp 2067-2078 (2022)
Abstract Background and Purpose Although cytotoxic platinum‐based adjuvant chemotherapy (pACT) has been recommended for patients with completely resected early‐stage (ES) non–small‐cell lung cancer (ES‐NSCLC), therapeutic regimens for NSCLC
Externí odkaz:
https://doaj.org/article/28d710f2b7614221858f539ac4e9e7ee
Publikováno v:
Oncogenesis, Vol 11, Iss 1, Pp 1-14 (2022)
Abstract Tumor suppressor p53 plays a central role in preventing tumorigenesis. Here, we unravel how p53 modulates mitochondrial dynamics to restrain the metastatic properties of cancer cells. p53 inhibits the mammalian target of rapamycin complex 1
Externí odkaz:
https://doaj.org/article/281e4f233db1471099111a4c33bf204f
Autor:
Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Yu-Ting Chou, Siraj M. Ali, D. Lucas Kerr, Victor R. Olivas, Jonathan Shue, Julia Rotow, Manasi K. Mayekar, Franziska Haderk, Nilanjana Chatterjee, Anatoly Urisman, Jia Chi Yeo, Anders J. Skanderup, Aaron C. Tan, Wai Leong Tam, Oscar Arrieta, Kazuyoshi Hosomichi, Akihiro Nishiyama, Seiji Yano, Yuriy Kirichok, Daniel S.W. Tan, Rafael Rosell, Ross A Okimoto, Trever G. Bivona
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 13 (2022)
Molecularly targeted cancer therapy has improved outcomes for patients with cancer with targetable oncoproteins, such as mutant EGFR in lung cancer. Yet, the long-term survival of these patients remains limited, because treatment responses are typica
Externí odkaz:
https://doaj.org/article/2ab24c64ef0a4efabc727bb6d4218018
Autor:
Chih-Shou Chen, Guan-Lun Gao, Dong-Ru Ho, Chih-Yi Lin, Yu-Ting Chou, Shan-Chun Chen, Min-Cong Huang, Wen-Ya Kao, Jyan-Gwo Joseph Su
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Prostate cancer is a major cause of death in males. Cyproterone acetate (CPA), the steroidal anti-androgen for part of androgen deprivation therapy, may block the androgen-receptor interaction and then reduce serum testosterone through its w
Externí odkaz:
https://doaj.org/article/78b4189db5554d3684b3a82e42a3a9a9
Autor:
Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou, Phui-Ly Liew, Lin-Yu Chen, Rui-Lan Huang, Hung-Cheng Lai, Lu-Te Chang
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-6 (2020)
Abstract Background Patients with ovarian clear cell carcinoma (OCCC) have a poor prognosis because they show low sensitivity to platinum-based chemotherapy. New treatments for refractory OCCC are urgently needed. Case presentation We present a patie
Externí odkaz:
https://doaj.org/article/3447f8789881452381b0e1e0cd7965cb